Your browser doesn't support javascript.
loading
A real-world study of panobinostat, weekly bortezomib and dexamethasone in a very heavily pretreated population of multiple-myeloma patients.
Bird, Sarah; Pawlyn, Charlotte; Nallamilli, Susanna; Sriskandarajah, Priya; Kaiser, Martin; Yong, Kwee; Popat, Rakesh; Rabin, Neil; Boyd, Kevin.
Afiliação
  • Bird S; The Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Pawlyn C; The Institute of Cancer Research, London, UK.
  • Nallamilli S; The Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Sriskandarajah P; The Institute of Cancer Research, London, UK.
  • Kaiser M; University College London Hospital NHS Foundation Trust, London, UK.
  • Yong K; The Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Popat R; The Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Rabin N; The Institute of Cancer Research, London, UK.
  • Boyd K; University College London Hospital NHS Foundation Trust, London, UK.
Br J Haematol ; 191(5): 927-930, 2020 12.
Article em En | MEDLINE | ID: mdl-33460042
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiplo Idioma: En Ano de publicação: 2020 Tipo de documento: Article